Download
1465-9921-6-8.pdf 1,20MB
WeightNameValue
1000 Titel
  • Molecular mechanisms of severe acute respiratory syndrome (SARS)
1000 Autor/in
  1. Groneberg, David A. |
  2. Hilgenfeld, Rolf |
  3. Zabel, Peter |
1000 Erscheinungsjahr 2005
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2005-01-20
1000 Erschienen in
1000 Quellenangabe
  • 6(1):8
1000 FRL-Sammlung
1000 Copyrightjahr
  • 2005
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.1186/1465-9921-6-8 |
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC548145/ |
1000 Publikationsstatus
1000 Begutachtungsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • Severe acute respiratory syndrome (SARS) is a new infectious disease caused by a novel coronavirus that leads to deleterious pulmonary pathological features. Due to its high morbidity and mortality and widespread occurrence, SARS has evolved as an important respiratory disease which may be encountered everywhere in the world. The virus was identified as the causative agent of SARS due to the efforts of a WHO-led laboratory network. The potential mutability of the SARS-CoV genome may lead to new SARS outbreaks and several regions of the viral genomes open reading frames have been identified which may contribute to the severe virulence of the virus. With regard to the pathogenesis of SARS, several mechanisms involving both direct effects on target cells and indirect effects via the immune system may exist. Vaccination would offer the most attractive approach to prevent new epidemics of SARS, but the development of vaccines is difficult due to missing data on the role of immune system-virus interactions and the potential mutability of the virus. Even in a situation of no new infections, SARS remains a major health hazard, as new epidemics may arise. Therefore, further experimental and clinical research is required to control the disease.
1000 Sacherschließung
gnd 1206347392 COVID-19
lokal Severe Acute Respiratory Syndrome
lokal SARS
lokal molecular mechanisms
lokal vaccination
lokal therapy
lokal Coronavirus
1000 Fächerklassifikation (DDC)
1000 Liste der Beteiligten
  1. https://frl.publisso.de/adhoc/uri/R3JvbmViZXJnLCBEYXZpZCBBLg==|https://frl.publisso.de/adhoc/uri/SGlsZ2VuZmVsZCwgUm9sZg==|https://frl.publisso.de/adhoc/uri/WmFiZWwsIFBldGVy
1000 Label
1000 Förderer
  1. Deutsche Forschungsgemeinschaft |
  2. Verband der Chemischen Industrie |
  3. Deutsche Atemwegsliga (DAG) |
  4. European Commission |
1000 Fördernummer
  1. Hi 611/4-1; Gr 2014/2-1
  2. -
  3. -
  4. -
1000 Förderprogramm
  1. -
  2. Fonds der Chemischen Industrie
  3. -
  4. -
1000 Dateien
  1. Molecular mechanisms of severe acute respiratory syndrome (SARS)
1000 Förderung
  1. 1000 joinedFunding-child
    1000 Förderer Deutsche Forschungsgemeinschaft |
    1000 Förderprogramm -
    1000 Fördernummer Hi 611/4-1; Gr 2014/2-1
  2. 1000 joinedFunding-child
    1000 Förderer Verband der Chemischen Industrie |
    1000 Förderprogramm Fonds der Chemischen Industrie
    1000 Fördernummer -
  3. 1000 joinedFunding-child
    1000 Förderer Deutsche Atemwegsliga (DAG) |
    1000 Förderprogramm -
    1000 Fördernummer -
  4. 1000 joinedFunding-child
    1000 Förderer European Commission |
    1000 Förderprogramm -
    1000 Fördernummer -
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6420303.rdf
1000 Erstellt am 2020-04-21T10:57:46.483+0200
1000 Erstellt von 122
1000 beschreibt frl:6420303
1000 Bearbeitet von 122
1000 Zuletzt bearbeitet Tue Apr 21 11:00:22 CEST 2020
1000 Objekt bearb. Tue Apr 21 11:00:06 CEST 2020
1000 Vgl. frl:6420303
1000 Oai Id
  1. oai:frl.publisso.de:frl:6420303 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source